CA
Candel Therapeutics, Inc.
CADL · NASDAQ
$11.85 +5.05% (+$0.57)
1M -7.85%
Market Cap $868.3M
P/E Ratio -
Div. Yield -
ROE 89.38%
Bulios Fair Price
$6.7
43.5% downside
Trenutna cena
$11.85
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CADL trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
14 /100
Expensive P/B 6.88x
P/E N/A
EV/EBITDA N/A
Growth
39 /100
Stable Book val. growth 2.86%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 36.74%
ROE 89.38%
ROA 42.53%
Debt
66 /100
Moderate Debt/Equity 0.39x
Current ratio 16.09x
Int. coverage -17.77x
Stability
19 /100
Unstable Beta -0.47x
EPS volatility 712.08%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CADL
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Paul-Peter Tak
Employees
55
Headquarters
Needham
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report